Biologics are recognized as one of the most promising areas for drug discovery and development in the 21st century. In recent years, biologics have been
On Aug 24th, Medicilon co-hosted the “Shanghai – Boston Drug Development International Collaboration Seminar” with Shanghai Center of Biomedicine Development and Shanghai Zhangjiang Biotech&Pharmaceutical Base
Dr. Chunlin Chen hosted the seminar. The seminar, “The Opportunities and Challenges of Generic Drugs Under New Circumstances” affiliated with Bio-Forum 2016, was successfully ended
Shanghai Medicilon Inc.